Hemanex has now raised $130 million. The funding comes as the company looks to expand into European commercial markets in 2023, according to a Nov. 7 Hemanex news release.
The company plans to keep the series B round open to investors for the next couple of weeks and is planning to launch a series C round in 2023.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
